Mesial Temporal Astrocyte Tau Pathology in the MRC-CFAS Ageing Brain Cohort
暂无分享,去创建一个
G. Lace | C. Brayne | F. Matthews | G. Savva | P. Ince | R. de Silva | J. Simpson | G. Lace | C. Brayne | P.G. Ince | S. B. Wharton | G.M. Savva | F.E. Matthews | R. de Silva | J.E. Simpson | S.B. Wharton | S. Wharton | J. Simpson | Fiona E. Matthews | Paul G. Ince | Carol Brayne | R. D. Silva
[1] C. Brayne,et al. Alterations in the blood brain barrier in ageing cerebral cortex in relationship to Alzheimer-type pathology: A study in the MRC-CFAS population neuropathology cohort , 2011, Neuroscience Letters.
[2] C. Duyckaerts,et al. Tau-positive grains are constant in centenarians’ hippocampus , 2011, Neurobiology of Aging.
[3] Thomas G Beach,et al. Neuropathological findings of PSP in the elderly without clinical PSP: possible incidental PSP? , 2011, Parkinsonism & related disorders.
[4] C. Brayne,et al. Association between APOE genotype, neuropathology and dementia in the older population of England and Wales , 2011, Neuropathology and applied neurobiology.
[5] C. Brayne,et al. Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain , 2010, Neurobiology of Aging.
[6] C. Brayne,et al. Population variation in oxidative stress and astrocyte DNA damage in relation to Alzheimer‐type pathology in the ageing brain , 2010, Neuropathology and applied neurobiology.
[7] G Forster,et al. Hippocampal tau pathology is related to neuroanatomical connections: an ageing population-based study. , 2009, Brain : a journal of neurology.
[8] Isidro Ferrer,et al. Argyrophilic grain disease. , 2008, Brain : a journal of neurology.
[9] B. Zlokovic. The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders , 2008, Neuron.
[10] Andrew Kertesz,et al. Argyrophilic thorny astrocyte clusters in association with Alzheimer’s disease pathology in possible primary progressive aphasia , 2007, Acta Neuropathologica.
[11] S. Wharton,et al. A brief history of tau: the evolving view of the microtubule-associated protein tau in neurodegenerative diseases. , 2007, Clinical neuropathology.
[12] Carol Brayne,et al. Cohort profile: the Medical Research Council Cognitive Function and Ageing Study (CFAS). , 2006, International journal of epidemiology.
[13] J. Schneider,et al. Neuropathology of older persons without cognitive impairment from two community-based studies , 2006, Neurology.
[14] C. Brayne,et al. Population-based neuropathological studies of dementia: design, methods and areas of investigation – a systematic review , 2006, BMC neurology.
[15] E. Hol,et al. Adult human subventricular, subgranular, and subpial zones contain astrocytes with a specialized intermediate filament cytoskeleton , 2005, Glia.
[16] S. Murayama,et al. Staging of Argyrophilic Grains: An Age‐Associated Tauopathy , 2004, Journal of neuropathology and experimental neurology.
[17] Udo Rüb,et al. High prevalence of thorn-shaped astrocytes in the aged human medial temporal lobe , 2004, Neurobiology of Aging.
[18] Keith A. Johnson,et al. Neuropathology of Cognitively Normal Elderly , 2003, Journal of neuropathology and experimental neurology.
[19] J. Holton,et al. Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule‐binding repeat domains as demonstrated by new specific monoclonal antibodies , 2003, Neuropathology and applied neurobiology.
[20] D. Dickson,et al. Argyrophilic Grain Disease Is a Sporadic 4‐Repeat Tauopathy , 2002, Journal of neuropathology and experimental neurology.
[21] Ian G. McKeith,et al. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales , 2001, The Lancet.
[22] Y Shibasaki,et al. Primary progressive aphasia with focal glial tauopathy , 2000, Neuropathology and applied neurobiology.
[23] A. Probst,et al. Astrocytes expressing hyperphosphorylated tau protein without glial fibrillary tangles in argyrophilic grain disease , 1999, Acta Neuropathologica.
[24] M. Laakso,et al. Astrogliosis and the ApoE Genotype , 1999, Dementia and Geriatric Cognitive Disorders.
[25] M. Tolnay,et al. REVIEW: tau protein pathology in Alzheimer’s disease and related disorders , 1999, Neuropathology and applied neurobiology.
[26] J. Cavanagh. Corpora-amylacea and the family of polyglucosan diseases , 1999, Brain Research Reviews.
[27] E. Vanmechelen,et al. Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205 , 1995, Neuroscience Letters.
[28] H. Braak,et al. A silver impregnation method for labeling both Alzheimer paired helical filaments and their polypeptides separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis , 1991, Neurobiology of Aging.
[29] C. Brayne,et al. Epidemiological neuropathology: the MRC Cognitive Function and Aging Study experience. , 2011, Journal of Alzheimer's disease : JAD.
[30] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[31] T. Tokuda,et al. Thorn-shaped astrocytes: possibly secondarily induced tau-positive glial fibrillary tangles , 2004, Acta Neuropathologica.
[32] M. Laakso,et al. Astrogliosis and the ApoE genotype. an immunohistochemical study of postmortem human brain tissue. , 1999, Dementia and geriatric cognitive disorders.
[33] M. Tolnay. Tau protein pathology in Alzheimer'sdisease and related disorders , 1999 .